In 2025, the sector in Australia reached a value of USD 5.51 billion.
Our market projections estimate the Australia Infusion Services Market size is expected to achieve USD 10.59 billion by 2033, supported by a CAGR of 8.5% for the forecast period.
Balanced public-private oncology delivery under the Pharmaceutical Benefits Scheme maintains predictable biologic reimbursement and steady infusion volumes.
Australian Institute of Health and Welfare cancer activity data indicate continued systemic therapy demand, reinforcing stable infusion capacity utilization nationwide.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]